450 related articles for article (PubMed ID: 32087356)
21. Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy.
Acosta J; Fernández-Armenta J; Penela D; Andreu D; Borras R; Vassanelli F; Korshunov V; Perea RJ; de Caralt TM; Ortiz JT; Fita G; Sitges M; Brugada J; Mont L; Berruezo A
Heart Rhythm; 2016 Jan; 13(1):85-95. PubMed ID: 26165946
[TBL] [Abstract][Full Text] [Related]
22. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Combined Endocardial-Epicardial Ablation Compared With Endocardial Ablation Alone in Patients Who Undergo Epicardial Access.
Killu AM; Mulpuru SK; Al-Hijji MA; Sugrue A; Munger TM; Hodge DO; McLeod CJ; Packer DL; Kapa S; Asirvatham SJ; Friedman PA
Am J Cardiol; 2016 Sep; 118(6):842-848. PubMed ID: 27553109
[TBL] [Abstract][Full Text] [Related]
24. Postmyocarditis ventricular tachycardia in patients with epicardial-only scar: a specific entity requiring a specific approach.
Berte B; Sacher F; Cochet H; Mahida S; Yamashita S; Lim H; Denis A; Derval N; Hocini M; Haïssaguerre M; Jaïs P
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):42-50. PubMed ID: 25257774
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy.
Henz BD; do Nascimento TA; Dietrich Cde O; Dalegrave C; Hernandes V; Mesas CE; Leite LR; Cirenza C; Asirvatham SJ; de Paola AA
J Interv Card Electrophysiol; 2009 Dec; 26(3):195-205. PubMed ID: 19757003
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.
Pokushalov E; Romanov A; Turov A; Artyomenko S; Shirokova N; Karaskov A
Heart Rhythm; 2010 Oct; 7(10):1406-10. PubMed ID: 20601157
[TBL] [Abstract][Full Text] [Related]
27. Epicardial mapping and ablation of ventricular tachycardia from the coronary venous system in post-coronary bypass patients.
Karimianpour A; Badertscher P; Payne J; Field M; Gold MR; Winterfield JR
J Interv Card Electrophysiol; 2023 Jan; 66(1):145-151. PubMed ID: 35581463
[TBL] [Abstract][Full Text] [Related]
28. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
[TBL] [Abstract][Full Text] [Related]
29. Ischemic ventricular tachycardia from below the posteromedial papillary muscle, a particular entity: Substrate characterization and challenges for catheter ablation.
Enriquez A; Briceno D; Tapias C; Shirai Y; Muser D; Liang J; Hayashi T; Santangeli P; Frankel DS; Supple GE; Schaller RD; Arkles J; Rodriguez D; Callans DJ; Marchlinski FE; Saenz L; Garcia FC
Heart Rhythm; 2019 Aug; 16(8):1174-1181. PubMed ID: 31085181
[TBL] [Abstract][Full Text] [Related]
30. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?
Reithmann C; Herkommer B; Fiek M
Clin Res Cardiol; 2016 Oct; 105(10):827-37. PubMed ID: 27294860
[TBL] [Abstract][Full Text] [Related]
31. Hybrid Ventricular Tachycardia Ablation after Failed Percutaneous Endocardial and Epicardial Ablation.
Haanschoten DM; Adiyaman A; Smit JJJ; Delnoy PPHM; Ramdat Misier AR; Porta F; Storm van Leeuwen RPH; Elvan A
Cardiology; 2020; 145(2):88-94. PubMed ID: 31707389
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of epicardial approach to catheter ablation of ventricular tachycardia - An institutional experience.
Pandian J; Kaur D; Yalagudri S; Devidutta S; Sundar G; Chennapragada S; Narasimhan C
Indian Heart J; 2017; 69(2):170-175. PubMed ID: 28460764
[TBL] [Abstract][Full Text] [Related]
33. Endocardial Scar-Homogenization With vs Without Epicardial Ablation in VT Patients With Ischemic Cardiomyopathy.
Mohanty S; Trivedi C; Di Biase L; Burkhardt JD; Della Rocca DG; Gianni C; MacDonald B; Mayedo A; Shetty SS; Zagrodzky W; Baqai F; Bassiouny M; Gallinghouse GJ; Horton R; Al-Ahmad A; Natale A
JACC Clin Electrophysiol; 2022 Apr; 8(4):453-461. PubMed ID: 35246406
[TBL] [Abstract][Full Text] [Related]
34. Exit sites on the epicardium rarely subtend critical diastolic path of ischemic VT on the endocardium: Implications for noninvasive ablation.
Bhaskaran A; Nayyar S; Porta-Sánchez A; Haldar S; Bokhari M; Massé S; Liang T; Zehra N; Farid T; Downar E; Nanthakumar K
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):520-527. PubMed ID: 30614114
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.
Zhang P; Tung R; Zhang Z; Sheng X; Liu Q; Jiang R; Sun Y; Chen S; Yu L; Ye Y; Fu G; Shivkumar K; Jiang C
Heart Rhythm; 2016 Nov; 13(11):2151-2158. PubMed ID: 27453126
[TBL] [Abstract][Full Text] [Related]
36. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
[TBL] [Abstract][Full Text] [Related]
37. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia.
Sosa E; Scanavacca M; D'Avila A; Piccioni J; Sanchez O; Velarde JL; Silva M; Reolão B
J Cardiovasc Electrophysiol; 1998 Mar; 9(3):229-39. PubMed ID: 9580377
[TBL] [Abstract][Full Text] [Related]
38. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.
Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K
Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of ICD electrograms analysis to distinguish endocardial vs epicardial ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
Kodali S; Shirai Y; Callans DJ; Zado ES; Marchlinski FE; Santangeli P
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1526-1534. PubMed ID: 31187564
[TBL] [Abstract][Full Text] [Related]
40. Imaging and epicardial substrate ablation of ventricular tachycardia in patients late after myocarditis.
Maccabelli G; Tsiachris D; Silberbauer J; Esposito A; Bisceglia C; Baratto F; Colantoni C; Trevisi N; Palmisano A; Vergara P; De Cobelli F; Del Maschio A; Della Bella P
Europace; 2014 Sep; 16(9):1363-72. PubMed ID: 24558183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
